India Panel Wants Johnson & Johnson To Pay Compensation Over Faulty Implants
The government released an expert panel’s report on alleged faulty hip replacement systems by a multinational company in India.
The government made public an expert panel's report on alleged faulty hip replacement systems by a multinational company in India followings demands of the affected patients to release the report.
The Central Drugs Standard Control Organization under the Health Ministry put up the report on its website yesterday, which said pharma giant Johnson & Johnson “suppressed” facts on the harm caused by surgeries which were conducted on patients in India using “faulty” hip replacement systems.
A group of patients, who suffered due to alleged faulty hip replacement surgeries by a multinational firm, have written to Union Health Minister JP Nadda, saying it is surprising that the media has been able to get the report while the persons directly affected have been kept in the dark.
“Indeed, we are unable to make sense of these claims and media reports being unaware of the contents of the expert committee report, which is still secret,” they had said.
The report suggested that the company pay a compensation of around Rs 20 lakh to the affected patients.
The high-powered committee to examine issues related to faulty ASR hip implants manufactured by DePuy International Ltd. - a subsidiary of Johnson & Johnson - was constituted by the Health ministry under the chairmanship of AK Aggarwal, former dean of the Maulana Azad Medical College.
The committee, in its report, said that it found to be evasive in providing the information desired by the committee regarding the design of ASR, patient details, compensation details, adverse drug reaction reports etc.
“The firm also appears to be delayed in passing information and awareness about the failure of ASR,” it said.